Incidence and molecular characterization of the extended spectrum beta lactamase-producing Escherichia coli isolated from urinary tract infections in Eastern Saudi Arabia

References

1. ↵
   1. Bagshaw S,
   2. Laupland K

   (2006) Epidemiology of intensive care unit-acquired urinary tract infections. Curr Opin Infect Dis 19:67–71.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Silverman J,
   2. Schreiber H,
   3. Hooton T,
   4. Hultgren S

   (2013) From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections. Curr Urol Rep 14:448–456.

   OpenUrlCrossRefPubMed
3. ↵
   1. Bergstrom S,
   2. Normark S

   (1979) Beta-lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC-mediated chromosomal beta-lactamase. Antimicrob Agents Chemother 16:427–433.

   OpenUrlAbstract/FREE Full Text
4. ↵
   1. Oliver A,
   2. Weigel L,
   3. Rasheed J,
   4. McGowan J,
   5. Raney P,
   6. Tenover F

   (2002) Mechanisms of decreased susceptibility to cefpodoxime in escherichia coli. Antimicrob Agents Chemother 46:3829–3836.

   OpenUrlAbstract/FREE Full Text
5. ↵
   1. Paterson DL,
   2. Bonomo RA

   (2005) Extended-spectrum-lactamases: A clinical update. Clin Microbiol Rev 18:657–686.

   OpenUrlAbstract/FREE Full Text
6. ↵
   1. Sari A,
   2. Biçmen M,
   3. Gülay Z

   (2013) Investigation of Plasmid Mediated AmpC Beta-Lactamases Among Escherichia coli and Klebsiella pneumoniae Isolated from Blood Cultures. Mikrobiyol Bul 47:582–591.

   OpenUrl
7. ↵
   1. Koneman EW,
   2. Allen SD,
   3. Dowell VR Jr.,
   4. Janda WM,
   5. Sommers HM,
   6. Winn WC Jr.

   (1988) Color atlas and textbook of diagnostic microbiology (Lippincott Williams and Wilkins, Philadelphia), 3rd ed.
8. ↵
   1. Drawz S,
   2. Bonomo R

   (2010) Three decades of lactamase inhibitors. Clin Microbiol Rev 23:160–201.

   OpenUrlAbstract/FREE Full Text
9. ↵
   1. Poirel L,
   2. Heritier C,
   3. Podglajen I,
   4. Sougakoff W,
   5. Gutmann L,
   6. Nordmann P

   (2003) Emergence in Klebsiella pneumoniae of a Chromosome-encoded SHV lactamase that compromises the efficacy of imipenem. Antimicrob Agents Chemother 47:755–758.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Cantón R,
    2. Coque T

    (2006) The CTX-M ß-lactamase Pandemic. Curr Opin Microbiol 9:466–475.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Latifpour M,
    2. Gholipour A,
    3. SadeghDamavandi M

    (2016) Prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in nosocomial and community-acquired urinary tract infections. Jundishapur J Microbiol 9:e31179.

    OpenUrl
12. ↵
    1. Garrec H,
    2. Drieux-Rouzet L,
    3. Golmard J,
    4. Jarlier V,
    5. Robert J

    (2011) Comparison of nine phenotypic methods for detection of extended-spectrum lactamase production by Enterobacteriaceae. J Clin Microbiol 49:1048–1057.

    OpenUrlAbstract/FREE Full Text
13. ↵
    1. Tawfik A,
    2. Alswailem A,
    3. Shibl A,
    4. Al-Agamy M

    (2011) Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia. Microbial Drug Resistance 17:383–388.

    OpenUrl
14. ↵
    1. Al-Agamy M,
    2. Shibl A,
    3. Tawfik A

    (2009) Prevalence and Molecular Characterization of Extended-spectrum ß-lactamase-producing Klebsiella pneumonia in Riyadh, Saudi Arabia. Ann Saudi Med 29:253–257.

    OpenUrlCrossRefPubMed
15. ↵
    1. Al Khateeb S,
    2. Al Shammari N,
    3. Al Zughaibi M,
    4. Ghazwani Y,
    5. Alrabeeah K,
    6. Albqami N

    (2016) The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones. Saudi Med J 37:860–863.

    OpenUrlAbstract/FREE Full Text
16. ↵
    1. Zhou G,
    2. Shi Q,
    3. Huang X,
    4. Xie X

    (2015) The Three Bacterial Lines of Defense against Antimicrobial Agents. Int J Mol Sci 16:21711–21733.

    OpenUrl
17. ↵
    1. Singh A,
    2. Kumar D,
    3. Ali M,
    4. Chander Y

    (2014) Antimicrobial susceptibility profile of extended spectrum and beta-lactamase (ESBL)-producing Escherichia coli from various clinical samples. Infect Dis (Auckl) 7:1–8.

    OpenUrlCrossRefPubMed
18. ↵
    1. Hassan H,
    2. Abdalhamid B

    (2014) Molecular characterization of extended-spectrum beta-lactamase producing Enterobacteriaceae in a Saudi Arabian Tertiary Hospital. J Infect Dev Ctries 8:282–288.

    OpenUrl